Wurtz; Nicholas R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wurtz; Nicholas R..The latest application filed is for "biaryl dialkyl phosphine oxide fpr2 agonists".

Company Profile

13.10.17

Wurtz; Nicholas R. - Pennington NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Biaryl Dialkyl Phosphine Oxide Fpr2 Agonists App 20220298186 - Shirude; Pravin Sudhakar ; et al.	2022-09-22
Pyrrolidinone Derivatives As Formyl Peptide 2 Receptor Agonists App 20220002281 - WURTZ; Nicholas R. ; et al.	2022-01-06
Phenylpyrrolidinone Formyl Peptide 2 Receptor Agonists App 20210371378 - Shirude; Pravin Sudhakar ; et al.	2021-12-02
Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists Grant 11,186,544 - Wurtz , et al. November 30, 2	2021-11-30
Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists Grant 11,180,490 - Smallheer , et al. November 23, 2	2021-11-23
Aryl heterocyclic piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists Grant 11,124,494 - Shirude , et al. September 21, 2	2021-09-21
Phenylpyrrolidinone formyl peptide 2 receptor agonists Grant 11,117,861 - Shirude , et al. September 14, 2	2021-09-14
Piperidinone formyl peptide 2 receptor agonists Grant 11,008,301 - Shirude , et al. May 18, 2	2021-05-18
Triazolopyridine inhibitors of myeloperoxidase and/or EPX Grant 11,008,317 - Kick , et al. May 18, 2	2021-05-18
Thioether triazolopyridine and triazolopyrimidine inhibitors of myeloperoxidase Grant 10,981,879 - Viet , et al. April 20, 2	2021-04-20
Aryl Heterocyclic Piperidinone Formyl Peptide 2 Receptor And Formyl Peptide 1 Receptor Agonists App 20210078971 - Shirude; Pravin Sudhakar ; et al.	2021-03-18
Piperidinone Formyl Peptide 2 Receptor And Formyl Peptide 1 Receptor Agonists App 20200299237 - Wurtz; Nicholas R. ; et al.	2020-09-24
Triazolopyridine Inhibitors Of Myeloperoxidase And/or Epx App 20200291016 - Kick; Ellen K. ; et al.	2020-09-17
Phenylpyrrolidinone Formyl Peptide 2 Receptor Agonists App 20200255375 - Kind Code	2020-08-13
Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists Grant 10,717,708 - Wurtz , et al.	2020-07-21
Piperidinone Formyl Peptide 2 Receptor Agonists App 20200207735 - Shirude; Pravin Sudhakar ; et al.	2020-07-02
Cyclopropyl Urea Formyl Peptide 2 Receptor And Formyl Peptide 1 Receptor Agonists App 20200199113 - Smallheer; Joanne M. ; et al.	2020-06-25
Phenylpyrrolidinone formyl peptide 2 receptor agonists Grant 10,676,431 - Shirude , et al.	2020-06-09
Piperidinone Formyl Peptide 2 Receptor And Formyl Peptide 1 Receptor Agonists App 20200123108 - Wurtz; Nicholas R. ; et al.	2020-04-23
Novel Use Of A Formyl Peptide Receptor 2/ Lipoxin A4 Receptor (fpr2/alx) Agonist For Treatment Of Heart Failure App 20200069644 - Ostrowski; Jacek ; et al.	2020-03-05
Phenylpyrrolidinone Formyl Peptide 2 Receptor Agonists App 20190270704 - Shirude; Pravin Sudhakar ; et al.	2019-09-05
Thioether Triazolopyridine And Triazolopyrimidine Inhibitors Of Myeloperoxidase App 20190031623 - Viet; Andrew Quoc ; et al.	2019-01-31
Piperidinone Formyl Peptide 2 Receptor And Formyl Peptide 1 Receptor Agonists App 20180327358 - Wurtz; Nicholas R. ; et al.	2018-11-15
Targeting Of The Formyl-peptide Receptor 2/lipoxin A4 Receptor (fpr2/alx) For Treatment Of Heart Disease App 20180325869 - Ostrowski; Jacek ; et al.	2018-11-15
Triazolopyridine and triazolopyrimidine inhibitors of myeloperoxidase Grant 9,920,075 - Wurtz , et al. March 20, 2	2018-03-20
Thioether Triazolopyridine And Triazolopyrimidine Inhibitors Of Myeloperoxidase App 20170247343 - Viet; Andrew Quoc ; et al.	2017-08-31
Triazolopyridine And Triazolopyrimidine Inhibitors Of Myeloperoxidase App 20170247396 - Wurtz; Nicholas R. ; et al.	2017-08-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.